Back to Search
Start Over
Pulmonary function in patients surviving to COVID-19 pneumonia.
- Source :
- Infection; 2021, Vol. 49 Issue 1, p153-157, 5p, 1 Chart, 1 Graph
- Publication Year :
- 2021
-
Abstract
- Purpose: The aim of our study was to assess respiratory function at the time of clinical recovery and 6 weeks after discharge in patients surviving to COVID-19 pneumonia. Methods: Our case series consisted of 13 patients with COVID-19 pneumonia. Results: At the time of clinical recovery, FEV1 (2.07 ± 0.72 L) and FVC (2.25 ± 0.86 L) were lower compared to lower limit of normality (LLN) values (2.56 ± 0.53 L, p = 0.004, and 3.31 ± 0.65 L, p < 0.001, respectively), while FEV1/FVC (0.94 ± 0.07) was higher compared to upper limit of normality (ULN) values (0.89 ± 0.01, p = 0.029). After 6 weeks pulmonary function improved but FVC was still lower than ULN (2.87 ± 0.81, p = 0.014). Conclusion: These findings suggest that COVID-19 pneumonia may result in clinically relevant alterations in pulmonary function tests, with a mainly restrictive pattern. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 03008126
- Volume :
- 49
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Infection
- Publication Type :
- Academic Journal
- Accession number :
- 148427242
- Full Text :
- https://doi.org/10.1007/s15010-020-01474-9